Hong-Lin Chan
National Tsing Hua University, Taiwan
Hong-Lin Chan is the Head of the National Tsing Hua University, Taiwan, for Quantitative Proteomics Group and has 10 years of experience in proteomic method development and application. Dr. Chan received his Ph.D. degree from University College London in 2005. After 2-year postdoctoral training in the Wolfson Institute for Biomedical Sciences, he got the current Professorship from NationalTsing Hua University in Taiwan. Dr. Chan's group has expertise in the preparation, separation, and quantification of proteins and posttranslational modifications using mass spectrometry and other methods. Dr. Chan was one of the first users of 2D-DIGE technology which is routinely used for protein expression profiling, and the group has also established platforms which perform quantitative phosphoproteomics and redox-proteomics analysis. Dr. Chan's group focused on serum biomarker discovery, characterising redox stress responses in cell models, mechanisms of cellular signalling, and proteomics-based studies on breast cancer, prostate cancer, and drug resistance formation. Methods include cell biology facilities, 2D-DIGE/MS, and quantitative 2D-LC-MS/MS expression profiling.

Dr. Chan's group has expertise in the preparation, separation, and quantification of proteins and posttranslational modifications using mass spectrometry and other methods. Dr. Chan was one of the first users of 2D-DIGE technology which is routinely used for protein expression profiling, and the group has also established platforms which perform quantitative phosphoproteomics and redox-proteomics analysis. Dr. Chan's group focused on serum biomarker discovery, characterising redox stress responses in cell models, mechanisms of cellular signalling, and proteomics-based studies on breast cancer, prostate cancer, and drug resistance formation. Methods include cell biology facilities, 2D-DIGE/MS, and quantitative 2D-LC-MS/MS expression profiling.

Dr. Monther Al-Alwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professorat Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc.and Ph.D. in ImmunologyfromDalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance. Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 21 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.

Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis.

Tibor Hortobágyi is an academic neuropathologist, head of department and chair at the University of Debrecen, Hungary, and president of the Hungarian Neuropathological Society. He completed training in histopathology and neuropathology and worked for 10 years at King’s College & King’s College Hospital in London where he is currently visiting senior lecturer. His main research interest is neurodegeneration. Tibor Hortobágyi is author on more than 100 research papers and numerous book chapters, with publications in Science and Nature Neuroscience, and editorial board member of several journals including Acta Neuropathologica. He is councillor of the European Confederation of Neuropathological Societies (EURO-CNS) and International Society of Neuropathology (ISN). He is devoted to neuropathology teaching and is Chairman of the Board of Examiners of the European Neuropathology Exam (EFN) and Advisor at the International Department of the Royal College of Pathologists.

Brain tumours; Neuropathology; Genetics; Animal models of diseases.

Alba Fricke was born in Tavaí (Paraguay), studied medicine in Heidelberg (Germany), Coimbra (Portugal), Montpellier (France) and Florianopolis (Brazil) and worked as a researcher at the Baker Heart and Diabetes Institute in Melbourne (Australia), mainly in the field of microparticles as transport vehicles for cellular microRNA and the role of specific microRNAs as biomarkers for cardiovascular disorders. During her residency at the Department for Plastic and Hand Surgery at the University Medical Center Freiburg (Germany) she focused her research on blood-borne microRNA signatures as biomarkers for different types of soft tissue sarcoma.

Research on blood-borne microRNA signatures as biomarkers for different types of soft tissue sarcoma.

Ali Ramazani is the Head of the Biotechnology Departments, School of Pharmacy, Zanjan University of Medical Sciences (ZUMS), Iran. He is also Head of Cancer Gene Therapy Research Center of ZUMS. After graduating in BSc of Medical Laboratory Sciences from Tehran University of Medical Sciences, he completed training in Human Genetics and received his Ph.D. degree on Medical Biotechnology from Pasteur Institute of Iran (2010). He is an Associate Professor at ZUMS. Dr. Ramazani has expertise in Bioinformatics, Proteomics, Metabolomics and cell culture methods. His research interest is antimalarial drug discovery, Toxico-metabolomics, biosensor development for cancer detection, mechanism based drug target identification, and monoclonal antibodies developments for different cancer targets

Anti-malarial Drug Discovery, System Biology, Proteomics, Cancer, Human Genetics, Bioinformatics, Gene Expression, Signaling, Pharmaceutical Biotechnology.

Prof. Andrea Nicolini, MD
Born in Massa (MS), Tuscany, Italy on June 12, 1947.
Specialty in Diseases & Conditions: Clinical Oncologist, with experience in malignant solid tumors, in particular breast cancer, colorectal cancer and their metastases, tumour markers, post-operative follow-up; physiopathology, immunology and immunotherapy of cancer.
Education & Fellowships: Medical studies at the University of Pisa, Medical Doctor degree magna cum laude, 1974, Postgraduate Diploma at Pisa University: Internal Medicine (1980), Pneumology (1984), Nuclear Medicine (1986). 1992: Winner of one of the 40 fellow-ships dispensed by Commission of the European Communities as part of the project “Europe against cancer”. 1993-1994: Winner of one of the fellow-ships dispensed by the Italian Association for Cancer Research (FIRC) and a travel grant by ISPO. 2007: Winner of a travel grant to attend the 9th Annual Lynn Sage Breast Cancer Symposium, Chicago 27-30 September.
Author of about 150 articles in peer reviewed journals. Regular reviewer for international journals in oncology. Invited guest editor of special issues by peer reviewed journals.

Specialty in Diseases & Conditions: Clinical Oncologist, with experience in malignant solid tumors, in particular breast cancer, colorectal cancer and their metastases, tumour markers, post-operative follow-up; physiopathology, immunology and immunotherapy of cancer.

With an education of Doctor in Veterinary Medicine and a PhD in Immunology, Bruno Gomes has more than ten years of experience in pharmaceutical companies (Sanofi, Pierre Fabre, iTeos Therapeutics) in Oncology and Immuno-Oncology drug discovery and translational research. He has developed strong expertise in oncology, immunology and drug development process, leading preclinical programs with targeted therapies and onco-immunology therapeutics.

1. Onco-immunology, immune checkpoints, tumor immune escape
2. Tumor models, syngeneic tumor models, xenografts, PDX, humanized models, spontaneous tumor models
3. Tumor biology, tumor microenvironnement
4. Pharmacology, new targets, new oncology drugs
5. Translational research, pharmacodynamic biomakers, patient selection, precision medicine

Daniel Nieto received his MSc and Ph.D in Photonics and Laser Technologies from NUI Galway (Ireland, 2010) and from the University of Santiago de Compostela (Spain, 2012), respectively. After a brief period as project manager at the non–profit Foundation IK4- CIDETEC, he returned to the University of Santiago de Compostela as pos-doctoral researcher. At the moment, he is a senior researcher at the National Center for Laser Applications in the National University of Ireland. His research interest is focused on microstructuring biomaterials with the aim of creating smart tissue scaffolds with integrated electrical, thermal and optical stimulation, all compatible with a future chip, for modelling cancer/cardiovascular pathologies.

At this moment, i am involved on the next projects related with the topic of your journal: Fabrication of a 3D bioinspired system by laser technologies for its application as preclinical vascular models and cell niche and creating smart tissue scaffolds with integrated electrical, thermal and optical stimulation for modelling cancer/cardiovascular pathologies.

Prof. Hanaa Hamdy Ahmed, Professor and Head of Hormones Department, Medical Research Division, National Research Centre. Birth Date (21/6/1963). BSc. (1985), MSc. (1990) and PhD (1998) - Faculty of Science-Cairo University. Assistant Professor, Hormones Department, Medical Research Division, National Research Centre (31/5/2003); Professor (1/6/2008),Vice president of Hormones Department (2010-2013) and Head of Hormones Department (4/2013-4/2015). Research experience in Medicinal Chemistry, Biochemistry, Hormones, Biophysics, Endocinology and Clinical Chemistry. 45 published papers in local scientific periodicals, 119 international periodicals and 20 international books. Supervised 28 masters and 37 PhDs. Participated in 26 local and 1 international scientific projects. Reviewed 17 local projects, 147 international papers, 29 local papers and 32 masters and PhDs. Attended 202 local conferences, 11 international conferences, 32 scientific meetings and 85 workshops and training courses. Participated in organizing 3 conferences for the Medical Research Division (January and December 2013) and Dec. 2014 and 2 workshops. Member in the Scientific Committees of the Scientific Production Examination for Positions of Professors and Assistant Professors at Supreme Council of Universities and the Scientific Committee for Basic Sciences at National Research Centre. Board member of the Arab Society for Medical Research and the Egyptian Association of Science and Technologies Biomaterials. Member at 18 local and 4 international scientific associations. Member of editorial board of 17 international journals, reviewer of 3 local and 40 international journals. Awarded the Scientific Encouraging Prize in Medical Sciences-National Research Centre-2006, Excellence Prize in Research Products for 2009 and 2011, Certificate of Merit for the research outputs for 2012 and 2013 and the Prize of Excellence at the National Research Center in the Field of Science and Technology, which serves the Advanced Medical Science (2014).

Research experience in Medicinal Chemistry, Biochemistry, Hormones, Biophysics, Endocinology and Clinical Chemistry.

Dr. Hsiu-Chuan Chou is currently working as an Associate Professor at National Hsinchu University of Education in Taiwan since 2013. Dr. Chou received her PhD degree from King’s College, University of London in 2005. After 2 year post-doctoral training in the Cell Motility and Cytoskeleton research section in the Randall Division, she took a Researcher offer at Biomedical Laboratories in Industrial Technology Research Institute of Taiwan to develop therapeutic stem cells and diagnostic MRI nanoparticles for 3 years. Later on, Dr. Chou is moving into academic research labs with strong collaborative ties to biotech companies and hospitals. Dr. Chou’s group focuses on: immune cell migration, podosomes dynamics, MRI nanoparticle validation as well as proteomic approaches for the phenotypic hallmark traits and cellular signaling pathways in targeting toxic effect and drug resistance of cancer treatment.

Immune cell migration, podosomes dynamics, MRI nanoparticle validation, proteomic approaches for cancer biomarker discovery and cellular signaling pathways in targeting therapeutic margin.

I, Dr. Imran Khan am currently working as Research Associate at Department of Surgery, University of Illinois at Chicago (UIC). Prior to this, I completed my doctorate in cancer biology and molecular therapeutics from All India Institute of Medical Sciences (A.I.I.M.S), New Delhi, India. It is one of the premier institutes for Research in India. I have been working exclusively on cancer biology particularly on the development of novel strategies for specifically combating tumour growth. I have a wide range of expertise in various biomedical techniques and the therapeutic system which I developed during my PhD thesis addresses the major limitations of all the current cancer therapies. The therapeutic system has been patented and my Research has been published in journals of enormous repute. My research interests include elucidating the programming of normal cells into cancer cells and devising strategies to generate tumour specific therapeutic modalities.

My research interests include elucidating the programming of normal cells into cancer cells and devising strategies to generate tumour specific therapeutic modalities.
Cell and Molecular Biology
Cancer Research/Tumor Biology
Tumor delivery systems
Non-coding RNAs
Epigenetics and stem cell biology

I am Greek from Larissa city, born 1998. I finished the high school in 1998 and then I started studying at the University of Ioannina, in the Department of Physics until 2003. I began my M.Sc, referred to the fields of photonics and materials, in October of the same year, in the Department of Physics, University of Ioannina. I started my Ph.D., focused in studying of bone minerals by spectroscopic methods in November 2007 in the laboratory of medical physics at the University of Ioannina. I have worked as a postdoc researcher in the Medical Physics Lab since February 2015. To conclude, I have worked in high schools as physics teacher where my recent job position is, as an adjunct professor of physics laboratories at the Technological Educational Institute of Larissa.

My research focuses to the study of Ca/P ratio (Ca: calcium, P: phosphorus) in bones through spectroscopic techniques and especially Auger spectroscopy. The aim of this research is to thoroughly explore the distribution of these two basic elements of bones. This could help to understand bone diseases due to changes of these two elements. Auger spectroscopy features many advantages like superior resolution and specificity. The combination of the distribution Ca/P ratio in bone surface with the bone mineral density and the distribution of mineral elements from electron microscopy helps to understand bones characteristics in healthy and disease.
Presently, I study the osteoporosis treatment through natural food. So, I combine different diet in animals with osteoporosis and I observe different in Ca/P ratio between healthy and treated animals in different bone sites. The measurements are realized through electron microscopy with energy dispersive X – ray analyzer (SEM – EDX).
My research as a postodoc includes the clinical study of skin lesions using Raman spectroscopy. So I study the chemical changes in skin during the skin lesion Basal Cell Carcinoma (BCC).
Moreover, my interests include the changes in bone minerals during chronic diseases (diabetes, multiple sclerosis) and also life style factors and the similarities with osteoporosis in Ca/P ratio.

Kenny Chitcholtan graduated from University of Canterbury, Christchurch, New Zealand in 2006. He took the first Post doctoral position at the Department of Surgery, University of Otago, Christchurch New Zealand. At the department of Surgery, he investigated the interaction of Helicobacter pylori, a bacterium that causes stomach cancer. Kenny became interested in a three dimensional (3D) cell culture and behaviour of tumour cells correlating with drug sensitivity. In 2009, he joined Department of Obstetrics and Gynaecology, University of Otago, Christchurch New Zealand. His current projects include drug sensitivity of ovarian cancer cells in ascitic fluid and the role of EGFR, Her-2 and c-Met in floating ovarian cancer cells. Kenny is using 3D cell cultures, a chicken embryo and mouse models to explore these studies.

3D cell cultures, a chicken embryo and mouse models to explore these studies

Dr. Luigi Laino
Responsible Service Dermatological Thermography Institute San Gallicano for Research and Care, Rome
Director Dermatological Venereologic Centre Rome,
Technical Consultant Dermatologist of the Court of Rome;
Expert in Clinical Thermography and Dermatoscopy
Appointment and biography in Who's Who in the World 2014, 2015
Appointment and biography in Who's Who in Medicine & Healthcare 2012;
Member European Society of Thermology;
Partner International Dermoscopy Society;
Member Italian Hospital Dermatologists Association;
Secretary of the Italian Federation of Sports Dermatology;
Member Roman Academy of Dermatology;
Shareholder Association Dermatology and Allergology Professional Environmental;
Shareholder Association Italian atopic eczema;
Member Consensus International Medical Thermography;
Jet Former Advanced Course in Pediatric Allergy and Immunology Pediatric Clinic of the University of Rome "La Sapienza".

Dermatology and Allergology
Clinical Thermography and Dermatoscopy
Cancer Research

Dr. Maoquan Chu received his Ph.D. degree from East China University of Science and Technology in 2001. He then did his postdoctoral work in school of life science and technology in Shanghai Jiaotong University, where he delved into nano-biomedicine. In 2004, he joined the school of life science and technology in Tongji University. He was granted the title of professor in 2008 at Tongji University. His research interfaces with nanomaterials and biomedical Engineering. His research focuses on cancer imaging and therapy using nanomaterials

Nano-biomaterials for cancer imaging and therapy

This section will be updated soon...!

Cancer Research
Medical Microbiology

This Section will be Updated Soon...!

Pharmaceutical Chemistry
Cancer Pharmacology

This Section will be Updated Soon..!

Cancer Research

This section will be Updated Soon...!

Pharmacy and Biotechnology
Toxicology
Cancer Research

Dr. Seyed Amir Jalali has more than 10 years’ experience in immunology and cancer research.
Following a Ph.D. in Immunology, he took up a position as researcher and lecturer in ShahidBeheshti University of Medical Sciences, Tehran, Iran.
His research interest is cancer immunotherapy and nano-immunology. He has several papers on this subject.
He currently has several Ph.D and master students

• Cancer vaccine development
• Immunotherapy
• Cancer genetics and immuno-genetics
• Leishmania vaccine development
• Nanocarriers (Liposome)

Presently working as a Professor of Pathology in Sri Aurbindo Medical College and PG Institute, Indore (MP). Involved in undergraduate and post graduate teaching , training, clinical research,quality assurance, administration and reporting.
Graduated (MBBS) from M.G.M. Medical College Indore. Postgraduated (DPB and MD.Pathology) from Seth G.S.Medical College Mumbai. Special interest in infertility and oncologic histopathology and cytology. I have a vast experience of reporting cytology, histopathology and bone marrow.
Work experincece: Lecturer and Reader of Pathology, Seth G.S.Medical College and KEM Hospital Mumbai; Associate Professor in R.D.Gardi Medical College,Ujjain (MP); Professor Pathology in Sri Aurbindo Medical College and PG Institute,Indore.
Published 28 papers in National and International journals.
Life Member of IMA, IAPM, ISHBT and Forum for Medical Ethics.
Ex President and ExSecretary of State and City Chapter of IAPM.
Sportman: Sport secretary, MGM Medical College. Represented MGM Medical College, Indore University and MP State in Aquatics. Silver Medalist in All Indian Interversity Aquatic Meet

Special interest in infertility and oncologic histopathology and cytology.

My name is Wei Li. I graduated in 2008 from Zaozhuang college with a Bachelor of biotechnology. In 2013, I obtained Ph.D degree studying the exact molecular mechanisms of Swainsonine (natural toxin) -inhibited luteal cell progesterone secretion and induced apoptosis at North West Agriculture and Forestry University, College of Veterinary, under the directin of Prof.Dewen Tong. Now, I continued my studies in Center of Medical Physics and Technology, Hefei Institutes of Physical Sciences, Chinese Academy of Sciences.

In our laboratory, the main objective of research is to understand the biochemical and molecular mechanisms of natural toxin, heavy metal or other compounds biological effects. We examine these mechanisms from in vivo and in vitro in order to understand the biological effects of these compounds that control the response of humans or animals to toxic chemicals. Our research is guided by general questions such as:
• Whether ingesting these compounds can interfere with development of the reproductive and nervous systems.
• What are the molecular mechanisms by which compounds disrupt reproductive?

Dr. Xiaobo Li got his MD degree from the Inner Mongolia University of Nationality, and got his Ph.D degree in Pecking Union Medical College, Tsinghua University. He had been worked in Mitchell Cancer Institute, the University of South Alabama for almost four years as a postdoctoral fellow. Now Dr. Li is the associated professor and works in the Pathology Department of Harbin Medical University. His research interest is the tumor microenvironments and cancer progression. On the one hand, he is endeavored in revealing the roles of hypoxia and cancer associated inflammation in the cancer progression, on the other hand, he is devoted in the cancer prevention by targeting tumor microenvironments and tumor stromal cells.

His research interest is the tumor microenvironments and cancer progression. On the one hand, he is endeavored in revealing the roles of hypoxia and cancer associated inflammation in the cancer progression, on the other hand, he is devoted in the cancer prevention by targeting tumor microenvironments and tumor stromal cells.

Dr. Jin Ding is an expert in the liver cancer research. He has published a lot of papers on the molecular mechanism of carcinogenesis and accordingly performed translation research based on those new findings. His current major interest is the signaling network of liver cancer and the regulation of liver cancer stem cells.

Screening of anti-tumor drug candidates.
Signal transduction in carcinogenesis.
signaling network of liver cancer and the regulation of liver cancer stem cells